Skip to main content

Table 1 Effect size by outcome and funding source

From: Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis

Outcome

Number of studies

Number of animals

Heterogeneity (I2)

Effect size* (95% CI)

Atherosclerosis

49

3498

73

−1.25 (−1.56, −0.94)

Funding Source

    

Industry

15

 

18

−0.73 (−1.00, −0.47)

Non-industry

23

 

84

−1.99 (−2.68, −1.31)

No Statement

11

 

0

−0.93 (−1.24, −0.61)

Bone

45

1986

89

0.42 (0.00, 0.83)

Funding Source

    

Industry

6

 

60

0.13 (−0.48, 0.73)

Non-industry

28

 

91

0.48 (−0.10, 1.06)

No Statement

11

 

80

0.39 (−0.36, 1.14)

  1. *Standardized Mean Difference As Estimated in DerSimonian Laird Random-Effects Models.